Irene Griswold-Prenner

Gründer bei Nitrase Therapeutics, Inc.

Health Technology

Consumer Services

Commercial Services

Aktive Positionen von Irene Griswold-Prenner

Unternehmen	Position	Beginn	Ende
Nitrase Therapeutics, Inc. Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY.	Technik-/Wissenschafts-/F&E-Leiter	01.06.2017	-
	Gründer	01.06.2017	-
	Direktor/Vorstandsmitglied	-	02.11.2021
	Vorstandsvorsitzender	01.06.2017	02.11.2021

Unternehmen	Position	Beginn	Ende
Elan Pharmaceuticals, LLC Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.	Technik-/Wissenschafts-/F&E-Leiter	-	-
The University of Chicago	Finanzdirektor/CFO	-	21.06.2011
The University of Chicago	Doktortitel	-	-
iPierian, Inc. iPierian, Inc. Pharmaceuticals: MajorHealth Technology ierian, Inc. developed and manufactured biopharmaceutical products. The firm's lead antibody, IPN007, represents a new approach to treating neurodegenerative disease by targeting a novel form of secreted Tau protein. The company was founded in 2007 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	21.06.2011	-

The University of Colorado

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1
Undergraduate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	3
iPierian, Inc. iPierian, Inc. Pharmaceuticals: MajorHealth Technology ierian, Inc. developed and manufactured biopharmaceutical products. The firm's lead antibody, IPN007, represents a new approach to treating neurodegenerative disease by targeting a novel form of secreted Tau protein. The company was founded in 2007 and is headquartered in South San Francisco, CA.	Health Technology
Elan Pharmaceuticals, LLC Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.	Health Technology
Nitrase Therapeutics, Inc. Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY.	Commercial Services